KONSUMSI KOPI MENURUNKAN RISIKO KEJADIAN PENYAKIT KARDIOVASKULAR
Abstract
Background: Coffee is among the most popular beverages worldwide and contain substantial amounts of caffeine, making caffeine themost widely consumed psychoactive agent. Apart from being a psychoactive stimulant, it turns out that caffeine has a positive potential for caffeine in reducing the incidence of diseases in the cardiovascular system. Objective: Analyze the benefits of coffee on the cardiovascular system. Method: An examination and analysis of research findings from literature searches are done both nationally and internationally using PubMed databases and Google Scholars in a literature review using a narrative methodology. Results: Caffeine increases the release of endothelial nitric oxide, diminishes insulin sensitivity, regulates lipogenesis less tightly, and possesses antioxidant qualities that can minimize the risk of cardiovascular disease. Conclusion: Coffee gives positive benefits to the cardiovascular system.
Downloads
References
Cornelis MC. The Impact of Caffeine and Coffee on Human Health. Vol. 11, Nutrients. 2019.
Van Dam RM, Hu FB, Willett WC. Coffee, Caffeine, and Health. N Engl J Med. 2020 Jul;383(4):369–78.
Ludwig IA, Clifford MN, Lean MEJ, Ashihara H, Crozier A. Coffee: biochemistry and potential impact on health. Food Funct 2014; 5: 1695-717
Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ. 2017 Nov;359:j5024.
Kim EJ, Hoffmann TJ, Nah G, Vittinghoff E, Delling F, Marcus GM. Coffee Consumption and Incident Tachyarrhythmias: Reported Behavior, Mendelian Randomization, and Their Interactions. JAMA Intern Med. 2021 Sep;181(9):1185–93.
Rahmawati R, Daniyati D. Hubungan Kebiasaan Minum Kopi Terhadap Tingkat Hipertensi. J Ners Community. 2016;7(2):149–61.
Gardener H, Rundek T, Wright C, Elkind M, Sacco R. Coffee and Tea Consumption are inversely associated with mortality in a multiethnic urban population. J Nutr. 2013;143(8):1299–308.
Tuminah S, Riyadina W. Hubungan Konsusmsi Kopi Terhadap Stroke Atau Penyakit Jantung 1580 Koroner. Gizi Indones. 2014;37(1):29–40.
Chieng D, Canovas R, Segan L, Sugumar H, Voskoboinik A, Prabhu S, et al. Effects of Habitual Coffee Consumption on Incident Cardiovascular Disease, Arrhythmia, and Mortality: Findings From Uk Biobank. J Am Coll Cardiol. 2022;79(9):1455.
Kim Y, Je Y, Giovannucci E. Coffee consumption and all-cause and cause-specific mortality: a meta-analysis by potential modifiers. Eur J Epidemiol. 2019 Aug;34(8):731–52.
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Sep;140(11):e596–646.
Voskoboinik A, Kalman JM, Kistler PM. Caffeine and Arrhythmias: Time to Grind the Data. JACC Clin Electrophysiol. 2018 Apr;4(4):425–32.
Konstantinidi M, Koutelidakis AE. Functional Foods and Bioactive Compounds: A Review of Its Possible Role on Weight Management and Obesity’s Metabolic Consequences. Med (Basel, Switzerland). 2019 Sep;6(3).
Voskoboinik A, Koh Y, Kistler PM. Cardiovascular effects of caffeinated beverages. Trends Cardiovasc Med. 2019 Aug;29(6):345–50.
Chieng D, Kistler PM. Coffee and tea on cardiovascular disease (CVD) prevention. Trends Cardiovasc Med. 2022 Oct;32(7):399–405.
Cornelis MC, Monda KL, Yu K, Paynter N, Azzato EM, Bennett SN, et al. Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genet. 2011 Apr;7(4):e1002033.
Canovas R, Segan L, Sugumar H, Voskoboinik A, Prabhu S, Ling H, et al. Dampak subtipe kopi pada insiden penyakit kardiovaskular , aritmia , dan kematian : hasil jangka panjang dari UK Biobank. 2022;1–10.
Copyright (c) 2024 Medika Alkhairaat : Jurnal Penelitian Kedokteran dan Kesehatan
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Medika Alkhairaat : Jurnal Penelitian Kedokteran dan Kesehatan agree to the following terms:
1. Authors retain copyright and grant Journal Medika Alkhairaat right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/) that allows others to remix, adapt, build upon the work non-commercially with an acknowledgement of the work’s authorship and initial publication in Journal Medika Alkhairaat.
2. Authors are permitted to copy and redistribute the journal’s published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Journal Medika Alkhairaat.